Trevi Therapeutics (TRVI) Earnings Date, Estimates & Call Transcripts $6.47 -0.14 (-2.12%) Closing price 04:00 PM EasternExtended Trading$6.44 -0.03 (-0.46%) As of 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Trevi Therapeutics Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 6After Market ClosesEstimatedActual EPS (Mar. 18) -$0.11 Beat By $0.01 Consensus EPS (Mar. 18) -$0.12 Trevi Therapeutics announced Q4 2024 earnings on March 18, 2025, reporting an EPS of -$0.11, which topped the consensus estimate of -$0.12 by $0.01. With a trailing EPS of -$0.47, Trevi Therapeutics' earnings are expected to decrease next year, from ($0.49) to ($0.51) per share. Conference CallConference Call TranscriptTRVI Upcoming EarningsTrevi Therapeutics' next earnings date is estimated for Tuesday, May 6, 2025, based off prior year's reporting schedules. Get Trevi Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Trevi Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTRVI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TRVI Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Trevi Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.11-$0.10-$0.11Q2 20252-$0.16-$0.11-$0.14Q3 20253-$0.17-$0.10-$0.13Q4 20253-$0.20-$0.10-$0.14FY 202510($0.64)($0.41)($0.51) Remove Ads Trevi Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)-------3/18/2025Q4 2024-$0.12-$0.11+$0.01-$0.11--11/6/2024Q3 2024-$0.12-$0.13 -$0.01-$0.13--8/8/2024Q2 2024-$0.11-$0.12 -$0.01-$0.12--5/7/2024Q1 2024-$0.09-$0.11 -$0.02-$0.11--3/20/2024Q4 2023-$0.10-$0.08+$0.02-$0.08--11/9/2023Q3 2023-$0.09-$0.08+$0.01-$0.08--8/10/2023Q2 2023-$0.09-$0.07+$0.02-$0.07--5/11/2023Q1 2023-$0.08-$0.06+$0.02-$0.06-- Trevi Therapeutics Earnings - Frequently Asked Questions When is Trevi Therapeutics's earnings date? Trevi Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on TRVI's earnings history. Did Trevi Therapeutics beat their earnings estimates last quarter? In the previous quarter, Trevi Therapeutics (NASDAQ:TRVI) reported ($0.11) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.12) by $0.01. Learn more on analysts' earnings estimate vs. TRVI's actual earnings. How can I listen to Trevi Therapeutics's earnings conference call? The conference call for Trevi Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Trevi Therapeutics's conference call transcript? The conference call transcript for Trevi Therapeutics's latest earnings report can be read online. Read Transcript How much profit does Trevi Therapeutics generate each year? Trevi Therapeutics (NASDAQ:TRVI) has a recorded net income of -$29.07 million. TRVI has generated -$0.47 earnings per share over the last four quarters. What is Trevi Therapeutics's EPS forecast for next year? Trevi Therapeutics's earnings are expected to decrease from ($0.49) per share to ($0.51) per share in the next year. More Earnings Resources from MarketBeat Related Companies HRMY Earnings TVTX Earnings JANX Earnings IRON Earnings AGIO Earnings APGE Earnings VERA Earnings GLPG Earnings KNSA Earnings SDGR Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of Earnings Remove Ads This page (NASDAQ:TRVI) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredAI Boom Takes a Shocking Turn…AI is Creating Fortunes… (but not where you think!) Bryce Paul and the team at Crypto101 just released a br...Crypto 101 Media | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredHere’s Why Tesla Insiders are Dumping SharesTesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our res...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
